AmyDawnBrockmeyerMD

Obstetrics & Gynecology • Seattle, WA

Gynecologic Oncology, Hospice & Palliative Medicine

Physician

Join to view full profile

Dr. Brockmeyer is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Brockmeyer's full profile

Already have an account?

Office
1100 9th Ave
Seattle, WA 98101
Phone+1 206-223-6600

Fax+1 206-341-1975

Education & Training

University of Southern California/Los Angeles General Medical Center (USC/LA General)Fellowship, Gynecologic Oncology, 2006 - 2009
Washington University/B-JH/SLCH ConsortiumResidency, Obstetrics and Gynecology, 2002 - 2006
Chicago Medical School at Rosalind Franklin University of Medicine and ScienceClass of 2002

Certifications & Licensure

CA State Medical License 2006 - Present
AK State Medical License 2024 - 2026
WA State Medical License 2009 - 2026
AZ State Medical License 2017 - 2020
American Board of Internal Medicine Hospice and Palliative Medicine
American Board of Obstetrics and Gynecology Obstetrics & Gynecology
American Board of Obstetrics and Gynecology Gynecologic Oncology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification HealthSentry EHR, Cerner Corporation, 2013
Fellow (FACOG) American Congress of Obstetricians and Gynecologists

Clinical Trials

Carboplatin, Paclitaxel and Gemcitabine Hydrochloride With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian, Epithelial, Primary Peritoneal, or Fallopian Tube Cancer Start of enrollment: 2007 Dec 06
Active, not recruiting
Phase 3
Diet and Physical Activity Change or Usual Care in Improving Progression-Free Survival in Patients With Previously Treated Stage II, III, or IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Start of enrollment: 2012 Jun 18
Recruiting
Phase 3
Pelvic Radiation Therapy or Vaginal Implant Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Stage I or Stage II Endometrial Cancer Start of enrollment: 2009 Mar 23
Active, not recruiting
Phase 3
Collecting Tumor Samples From Patients With Gynecological Tumors Start of enrollment: 1992 Jun 01
Completed
Changes in Brain Function in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Who Are Receiving Chemotherapy Start of enrollment: 2010 Apr 01
Completed
Join now to see all

Publications & Presentations

PubMed

1 citations
High-grade squamous intraepithelial lesion cervicovaginal paps with negative high-risk HPV testing, a prospective study with histological follow-up.
S Nicholas Agoff, Amy D Brockmeyer, Allison M Barrie, Julie Larson
Diagnostic Cytopathology. 2023-08-01
1 citations
Factors associated with burnout among minimally invasive gynecologic surgery fellows.
Kelli McEntee, Hannah Koenig, Rohan Hattiangadi, Megan Loring, Amy Brockmeyer
AJOG Global Reports. 2022-08-01
4 citations
Gynecologic Oncology and Inclusion of Women Into the Surgical Workforce: The Canary in This Coal Mine.
Linda J Hong, Lisa Rubinsak, Michelle F Benoit, Deanna Teoh, Uma Chandavarkar
Frontiers in Oncology. 2022-01-01

Press Mentions

Seattle’s the 10th Most Burned Out City in the CountryNovember 8th, 2022

Professional Memberships

American College of Obstetricians and Gynecologists
Fellow